|
Volumn 33, Issue 11, 2005, Pages 1018-1022
|
Atorvastatin reduces the expression of COX-2 mRNA in peripheral blood monocytes in patients with acute myocardial infarction and modulates the early inflammatory response
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ATORVASTATIN;
CYCLOOXYGENASE 2;
HEPTANOIC ACID DERIVATIVE;
INTERLEUKIN 6;
MESSENGER RNA;
PTGS2 PROTEIN, HUMAN;
PYRROLE DERIVATIVE;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
FEMALE;
GENETICS;
HEART INFARCTION;
HUMAN;
INFLAMMATION;
MALE;
METABOLISM;
MIDDLE AGED;
MONONUCLEAR CELL;
RANDOMIZED CONTROLLED TRIAL;
AGED;
CYCLOOXYGENASE 2;
FEMALE;
HEPTANOIC ACIDS;
HUMANS;
INFLAMMATION;
INTERLEUKIN-6;
LEUKOCYTES, MONONUCLEAR;
MALE;
MIDDLE AGED;
MYOCARDIAL INFARCTION;
PYRROLES;
RNA, MESSENGER;
|
EID: 43249117379
PISSN: 02533758
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|